Abstract
We studied clinical availability ofCAPIOX SX in comparison with UNIVOX and MENOX AL6000 in relation to gas exchange performance. One hundred and nine patients who underwent various cardiac operations with CPB were derived into 3 groups, CAPIOX SX group (group C; 58 patients), UNIVOX group (group U; 29 patients) and MENOX group (group M; 22 patients). There were no significant diffemces among the 3 groups in regard to age, sex, weight, BSA, CPB time, aortic clamping time and minimum rectal temperature. Carbon dioxide elimination capacity of group C was almost equal to that of group U and better than that of group M. Effective lung blood flow ratio (QP/QT) showed an enough oxygene uptake capacity in all groups. An initial priming volume was significatly lower in group C than that of the other two groups. We concluded that CAPIOX SX is one of the usefull oxygenator for clinical application from the standpoint of the gas exchange performance.
